Quadrature Capital’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2,830
Closed -$261K – 1616
2025
Q4
$261K Buy
+2,830
New +$271K ﹤0.01% 890
2025
Q3
– Sell
-8,462
Closed -$1.1M – 1257
2025
Q2
$1.1M Buy
8,462
+3,582
+73% +$519K 0.02% 394
2025
Q1
$778K Sell
4,880
-4,238
-46% -$767K 0.02% 485
2024
Q4
$1.69M Buy
9,118
+3,868
+74% +$751K 0.03% 334
2024
Q3
$1.11M Sell
5,250
-8,007
-60% -$1.39M 0.03% 331
2024
Q2
$1.78M Buy
+13,257
New +$2.51M 0.03% 335
2023
Q4
– Sell
-125,202
Closed -$24.8M – 1252
2023
Q3
$24.8M Buy
125,202
+62,516
+100% +$15.8M 0.51% 48
2023
Q2
$20.3M Sell
62,686
-13,956
-18% -$3.99M 0.45% 58
2023
Q1
$17.9M Buy
76,642
+66,015
+621% +$16.7M 0.49% 56
2022
Q4
$2.68M Buy
+10,627
New +$2.27M 0.08% 210
2021
Q1
– Sell
-10,721
Closed -$2.02M – 1007
2020
Q4
$2.02M Buy
+10,721
New +$1.75M 0.1% 175
2020
Q1
– Sell
-7,367
Closed -$546K – 593
2019
Q4
$546K Buy
+7,367
New +$474K 0.02% 337

Other funds holding INSP

Quadrature Capital's INSP Position: Q1 2026 in Review

Quadrature Capital sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 2,830 shares — an estimated $261K sold.

Quadrature Capital first reported a position in INSP in Q4 2019 and held it in 12 quarters. The position peaked at $24.8M in Q3 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Quadrature Capital reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 2,830 Inspire Medical Systems shares in Q1 2026, an estimated $261K.
  • Quadrature Capital first reported a position in Inspire Medical Systems in Q4 2019 and held it in 12 quarters.
  • Quadrature Capital's Inspire Medical Systems position peaked at $24.8M in Q3 2023.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.